What is a key pediatric consideration in IBD management?

• A. Growth monitoring and exclusive enteral nutrition as primary therapy in Crohn's.
• B. Avoid nutritional interventions and focus on surgery.
• C. Psychosocial aspects are not a priority in management.
• D. Puberty timing is not affected by IBD in children.

Answer: (A)

Growth and nutrition are central in pediatric IBD because inflammation can impair height gain and overall development. Regular growth monitoring—tracking height velocity, weight, and body mass index—helps identify growth issues early and guides treatment decisions. Exclusive enteral nutrition is a preferred induction therapy for pediatric Crohn's disease because it reduces intestinal inflammation, supports mucosal healing, and promotes catch-up growth without the side effects of steroids. Typically used for several weeks, it provides complete, balanced nutrition and helps normalize growth trajectories, which is a primary pediatric objective. After remission, plans focus on maintaining growth and nutritional status while preventing relapse, with ongoing attention to dietary management and psychosocial support. Other options underestimate the importance of nutrition or growth and overlook how IBD can affect puberty and development.